Moracizinum [INN-Latin]
Brand names,
Moracizinum [INN-Latin]
Analogs
Moracizinum [INN-Latin]
Brand Names Mixture
Moracizinum [INN-Latin]
Chemical_Formula
C21H21N
Moracizinum [INN-Latin]
RX_link
http://www.rxlist.com/cgi/generic2/naft.htm
Moracizinum [INN-Latin]
fda sheet
Moracizinum [INN-Latin]
msds (material safety sheet)
Moracizinum [INN-Latin]
Synthesis Reference
No information avaliable
Moracizinum [INN-Latin]
Molecular Weight
287.398 g/mol
Moracizinum [INN-Latin]
Melting Point
No information avaliable
Moracizinum [INN-Latin]
H2O Solubility
No information avaliable
Moracizinum [INN-Latin]
State
Solid
Moracizinum [INN-Latin]
LogP
5.62
Moracizinum [INN-Latin]
Dosage Forms
Cream; Gel (1%)
Moracizinum [INN-Latin]
Indication
For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.
Moracizinum [INN-Latin]
Pharmacology
Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative. The following in vitro data are available, but their clinical significance is unknown. Naftifine has been shown to exhibit fungicidal activity in vitro against a broad spectrum of organisms including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Epidermophyton floccosum, and Microsporum canis, Microsporum audouini, and Microsporum gypseum; and fungistatic activity against Candida species including Candida albicans. However it is only used to treat the organisms listed in the indications.
Moracizinum [INN-Latin]
Absorption
Following single topical applications of 3H-labeled naftifine gel 1% to the skin of healthy subjects, up to 4.2% of the applied dose was absorbed.
Moracizinum [INN-Latin]
side effects and Toxicity
No information avaliable
Moracizinum [INN-Latin]
Patient Information
No information avaliable
Moracizinum [INN-Latin]
Organisms Affected
Yeast and other fungi